Overdose/Toxicities
Categories:
- General Side Effects
    
- Alpha-1 Antagonism (Norepinephrine)
        
- Significant orthostatic hypotension/tachycardia
 - MC: Risperidone/Paliperidone, Clozapine, Thioridazine, Trazodone
 
 - Dopamine receptor antagonist
        
- Metoclopramide
            
- For nausea and vomiting, may have EPS
 
 
 - Metoclopramide
            
 - Histamine Antagonism (Histamine)
        
- Sedation, appetite stimulation, weight gain
 - MC: Quetiapine (most sedating), Olanzapine (weight), Clozapine (weight), Thioridazine
 
 - Muscarinic Antagonism (Acetylcholine)
        
- Anticholinergic – Delirium, fever, tachycardia, flushing, dry mucus membranes, constipation, Confusion and hallucinations
 - MC: Olanzapine, Clozapine, Thioridazine, Chlorpromazine
 
 - Side Effect Monitoring
        
- EKG
            
- Amitriptyline/TCAs
 
 - CBC
            
- Clozapine (Agranulocytosis) weekly but not carbamazepine
 
 - Plasma levels
            
- Lithium, valproate
 
 - Falls
            
- TCAs and Benzos
 
 - Glucose
            
- Clozapine after 6 months
 
 - Dextromethorphan (cough syrup)
            
- Dissociative symptoms and hallucinations
 - Add Quetiapine to treat Pseudobulbar Affect
 
 
 - EKG
            
 
 - Alpha-1 Antagonism (Norepinephrine)
        
 
| Antipsychotic Extrapyramidal Effects – “ADAPT” | Pharmacotherapy | | — | — | | Acute Dystonia** (4 hours)** |
- Sudden, sustained contraction of neck, mouth, tongue and eye muscles |
 - Benztropine
 - Diphenhydramine | | Akathisia** (Days to weeks)** |
 - Subjective inner restlessness, inability to sit still, wanting to walk off
 - Dose dependent |
 - Benzodiazepine (Lorazepam)
 - Low-Dose BB (Propranolol)
 - Benztropine | | Parkinsonism** (Weeks to months)** |
 - Gradual-onset tremor, rigidity and bradykinesia |
 - Benztropine≥
 - Amantadine
 - Trihexyphenidyl | | Tardive dyskinesia** (4 months)** |
 - Gradual onset after prolonged therapy (≥6m): dyskinesia of mouth, face, trunk, extremities |
 - Valbenazine
 - Deutetrabenazine
 - 
    
Switch to Clozapine or Quetiapine |
 - Acetaminophen Overdose
    
- Gastroenteritis (non-specific) within hours, hepatoxicity within 1-2 days
        
- Leading cause of hepatic failure in US
 
 - Treatment
        
- Activated Charcoal and N-Acetylcysteine
 - Liver Transplant
 
 
 - Gastroenteritis (non-specific) within hours, hepatoxicity within 1-2 days
        
 - Alcohol Intoxication
    
- Slurred speech, incoordination, unsteady gait, attention/memory impairment, stupor, nystagmus
 
 - Alcohol/Methanol Overdose
    
- Anion Gap Metabolic Acidosis
 - Fomepizole
        
- Inhibits alcohol dehydrogenase
 
 
 - Alcohol Ketoacidosis
    
- Slurred speech, unsteady gait, altered mentation
 - High Osmolar gap
 - Increased anion gap
 - Metabolic acidosis due to ketosis
 
 - Alcohol Withdrawal
    
- Symptoms
        
- Tachycardia, diaphoresis, anxiety, hallucinations, Seizures
            
- Macrocytic anemia
 
 - Mild (6-24h) – anxiety, insomnia, tremors, diaphoresis, palpitations, GI upset, intact orientation
 - Seizures (12-48h) – single or multiple generalized tonic, clonic
 - Alcoholic hallucinosis (12-24h) – visual, auditory, or tactile; intact orientation
 - Delirium Tremens (48-96h) – unstable vitals, hallucinations, confusion
 
 - Tachycardia, diaphoresis, anxiety, hallucinations, Seizures
            
 - Withdrawal Prophylaxis
        
- Chlordiazepoxide, Diazepam (medium-acting)
 
 - Treatment
        
- IV Lorazepam ≥ Chlordiazepoxide
            
- Especially in Liver disease
 
 - IVF, Thiamine, Folate
            
- Thiamine prior to glucose
 
 
 - IV Lorazepam ≥ Chlordiazepoxide
            
 
 - Symptoms
        
 - Anticholinergic Poisoning
    
- Treatment
        
- Physostigmine (cholinesterase inhibitors)
 
 
 - Treatment
        
 - Arsenic Poisoning
    
- Mechanism
        
- Binds to sulfhydryl groups
 - Disrupts cellular respiration and gluconeogenesis
 
 - Sources
        
- Pesticides, insecticides
 - Contaminated water, often from wells
 - Pressure-treated wood
 - Miners, smelters
 
 - Clinical
        
- Acute: Garlic breath, vomiting, watery diarrhea, QTc prolongation
            
- Dehydration secondary to vomiting and diarrhea
 - Seizure, delirium, coma, torsades de pointes
 - Acute tubular necrosis
 - Painful paresthesia, ascending weakness
 
 - Chronic: Pigmentation, hyperkeratosis, stocking-glove neuropathy
            
- Cancer: Skin, bladder, kidney, and/or lung
 
 - Mees Lines (Leukonychia striata) on the nails (hypo/hyperpigmented)
 
 - Acute: Garlic breath, vomiting, watery diarrhea, QTc prolongation
            
 - Diagnosis: Elevated urine Arsenic Levels
 - Treatment
        
- IM Dimercaprol (British anti-Lewisite)
 - DMSA (meso-2,3-dimercaptosuccinic acid, Succimer)
 
 
 - Mechanism
        
 - Barbiturate Overdose
    
- Phenobarbital
 - Weak Acids
 - Treatment
        
- Secure airway
 - Enhance elimination with Sodium Bicarbonate
            
- Alkalinization of the urine
 
 
 
 - Benzodiazepine Overdose
    
- Only Benzos = CNS depression with normal vitals
        
- Altered LOC, ataxia, slurred speech
 
 - Benzos + Alcohol = CNS depression with abnormal vitals
        
- Alcohol will cause bradycardia, hypotension, respiratory depression, hyporeflexia
 
 - Treatment
        
- RR Normal (12-20)
            
- Supportive Treatment
 
 - Emesis, Lavage, Charcoal
 - 1 Time Acute Overdose
            
- Flumazenil
                
- Avoid Flumazenil if chronic benzo user
 - Partial agonist, may precipitate withdrawal/seizures
 - Fixes CNS depression, less effective for respiratory
 - SE: Re-sedation, hypotension, hypertension, seizures in long term users, arrhythmias, angina
 
 
 - Flumazenil
                
 
 - RR Normal (12-20)
            
 
 - Only Benzos = CNS depression with normal vitals
        
 - Beta Blocker Overdose
    
- Bradycardia, AV block, and diffuse wheezing in a CAD patient
 - Drowsiness, fatigue, depression, Bradycardia, Torsade de points, worsening HF, hypertriglyceridemia, bronchoconstriction, ED, Weight gain
 - Treatment
        
- Hypotension: IV Glucagon
 - Atropine, IV fluids
 
 
 - Carbon Monoxide Poisoning
    
- Treatment
        
- 100% O2
 - Hyperbaric Oxygen if CO is ≥25-40%
            
- Lower if pregnant
 
 
 
 - Treatment
        
 - Cocaine Toxicity
    
- Inhibits norepinephrine reuptake into the sympathetic neuron (potentiating sympathomimetic actions)
        
- Alpha and beta receptor stimulation results in coronary vasoconstriction and increased HR, Systemic BP, and Myocardial O2 demand
 - Enhances thrombus formation by promoting platelet activation and aggregation
 
 - Age <30 w/o FH, severe or malignant hypertension, resistant hypertension, sudden rise in BP
 - Sympathetic hyperactivity
 - Symptoms
        
- Personality/mood changes, sleep loss, weight loss, financial difficulties
 - Chest pain, epistaxis, rhinitis, headaches
            
- Cocaine-related Chest Pain (CRCP)
                
- Can occur due to non-cardiac causes (hemorrhagic alveolitis, pneumothorax)
 
 
 - Cocaine-related Chest Pain (CRCP)
                
 - Hypertension, tachycardia, dilated pupils, psychomotor agitation, tremors
 
 - Complications
        
- Seizures, Acute MI, Aortic Dissection, Intracranial hemorrhage
 
 - Diagnosis: Urine Drug Screen
 - Treatment of NSTEMI/Chest Pain:
        
- Benzodiazepines for BP and Anxiety and O2 (lorazepam, diazepam)
            
- Reduce sympathetic outflow (alleviate tachycardia, hypertension)
 - +/- Phentolamine if above doesn’t work
 
 - Aspirin
 - Nitroglycerin and CCBs for pain
 - Beta blockers are contraindicated
            
- Would worsen coronary vasoconstriction (unopposed alpha-adrenergic stimulation)
 
 - No fibrinolytics
 - +/- Immediate Cardiac Catheterization
 
 - Benzodiazepines for BP and Anxiety and O2 (lorazepam, diazepam)
            
 
 - Inhibits norepinephrine reuptake into the sympathetic neuron (potentiating sympathomimetic actions)
        
 - Cyanide Accumulation and Cyanide Toxicity
    
- Cyanide is a potent inhibitor of cytochrome oxidase-a3 in the mitochondrial ETC
        
- Inhibits cellular respiration
 
 - 
        
RF: Smoke inhalation (Mc toxicity in house fires)
- Up to 90% of pts in house fires, only 35% have CO poisoning
 - Sodium Nitroprusside for hypertensive emergency
            
- Prolonged use can lead to toxicity
 - More common in patients with renal insufficiency, signs of CHF
 - Onset is ~14-24 hours
 
 
 - Symptoms
        
- Skin: Flushing before cyanosis
 - CNS: HA, AMS, seizures, coma, confusion, agitation
 - CV: Arrhythmias
 - Resp: Tachypnea followed by respiratory depression, Pulmonary edema
            
- BP instability
 
 - GI: Pain, nausea, vomiting
            
- “Almond like” odor to the breath
 
 - Renal: Metabolic acidosis (lactic acidosis), Renal failure
            
- Bright red venous blood (elevated ventral venous oxyhemoglobin saturation
 
 
 - Treatment
        
- Decontamination
            
- Dermal
                
- Remove clothing
 
 - Ingestion
                
- Activated charcoal
 
 - Antidotes
                
- 1) Hydroxocobalamin
                    
- Removes cyanide from mitochondrial respiratory system
 
 - 2) Sodium Thiosulphate
                    
- Slower onset, can’t be given with #1 or through the same catheter
 
 - 3) Sodium Nitrite
                    
- Only if ingested
 - Can’t be used in house fire victims due to synergistic effect with CO
 
 
 - 1) Hydroxocobalamin
                    
 
 - Dermal
                
 - Respiratory
            
- No mouth-to-mouth resuscitation
 - Use supplemental O2/intubation
 
 
 - Decontamination
            
 
 - Cyanide is a potent inhibitor of cytochrome oxidase-a3 in the mitochondrial ETC
        
 - Digitalis Toxicity
    
- Blocks na/k ATPase in myocardial cells
        
- Leading to influx of calcium, increased contractility, increased SV
 - Prolongs refractory period reducing ventricular rate
 
 - Features
        
- Characteristic ST depression with concave-up morphology “hockey stick”
 - AKI w/hyperkalemia and increased creatinine
 - Pain, nausea, vomiting
 - Confusion
 - Yellow halos around light, scotomas, blindness
 
 
 - Blocks na/k ATPase in myocardial cells
        
 - Ethylene Glycol Ingestion
    
- Symptoms
        
- Flank Pain, hematuria, oliguria, cranial nerve palsies, tetany
 
 - Labs
        
- High Osmolar gap
 - Increased anion gap
 - Metabolic acidosis
 - Calcium oxalate crystals in the urine
 
 - Treatment
        
- Fomepizole or Ethanol
 
 
 - Symptoms
        
 - Heparin
    
- Treatment
        
- Protamine
 
 
 - Treatment
        
 - Isopropyl Alcohol Ingestion
    
- CNS depression, deconjugate gaze, absent ciliary reflex
 - High Osmolar gap
 - No Increased Anion Gap
 - No Metabolic acidosis
 - Treatment
        
- Supportive Care
 
 
 - Malignant Hypertension (Hypertensive Crisis)
    
- Binds to RYR1R causing CA2+ release.
        
- MAOI + tyramine or stimulant
            
- Prevents breakdown of tyramine in gut
 - Enhances peripheral NE effects increasing BP
 
 
 - MAOI + tyramine or stimulant
            
 - Symptoms
        
- Headache following a meal (tyramine)
 - Hypertension, sweating, HA, vomiting
 - Sympathomimetic effect (hypertension)
 
 - Labs
        
- Increased BUN
 
 - Complications: Stroke, intracranial bleeding, death, rhabdomyolysis
 - Treatment
        
- Stop agent
 - IV phentolamine
 - Dantrolene
 - Nifedipine can be helpful
 
 - Thyroxine (T4) is treated with IV thyroxine for myxedema
        
- Coma required more
 
 
 - Binds to RYR1R causing CA2+ release.
        
 - Methanol Ingestion
    
- Visual Blurring, central scotomata, afferent pupillary defect, altered mentation, epigastric pain, hyperemic optic disc
 - High Osmolar gap
 - Increased anion gap
 - Metabolic acidosis
 - Treatment
        
- Fomepizole (inhibits the alcohol dehydrogenase that converts methanol to formaldehyde)
 - Ethanol
 
 
 - Methemoglobinemia
    
- Formed by the oxidation of ferrous to ferric iron in hemoglobin
 - Left shirt in the O2 curve because ferric iron cannot bind oxygen and this o2 binds tighter to ferrous iron in hemoglobin
 - Functional anemia
 - Causes: Dapsone, nitrates, topical/local anesthetics
 - Treatment
        
- Methylene Blue
 
 
 - Neuroleptic Malignant Syndrome (NMS)
    
- Antagonism of Dopamine (D2) receptors in the nigrostriatal pathway
        
- Can occur with every class of antipsychotics
 
 - Symptoms
        
- Slow onset, clouding of consciousness (over 1-3 days w/delirium being the 1st symptom)
 - Fever ≥104F, confusion, delirium or catatonia
 - Muscle rigidity (Lead-pipe), General muscle rigidity
 - Autonomic instability (Tachypnea, hypertension, tachycardia, dysrhythmia)
 - Abnormal vitals, sweating, mydriasis
 
 - Labs
        
- Increased CPK, LFTs, WBCs
 - Myoglobin in urine
 
 - Treatment
        
- Stop antipsychotics or restart dopamine agents
 - Antipsychotic meds
 - May have increases Creatine Kinase and WBCs
 - IV fluids, supportive care; ICU
 - Benzodiazepines
 - Dantrolene (skeletal muscle relaxant) or bromocriptine (dopamine agonist), amantadine (dopamine agonist) if refractory
 
 
 - Antagonism of Dopamine (D2) receptors in the nigrostriatal pathway
        
 - Opioids
    
- Treatment
        
- Buprenorphine
            
- Partial mu agonist, kappa antagonist
 - Treats withdrawal and chronic pain
 - Combined with naloxone (blocks receptor)
 
 - Naltrexone
            
- Treats dependence, not withdrawal
 
 - Methadone
            
- Treats withdrawl
 
 
 - Buprenorphine
            
 
 - Treatment
        
 - Organophosphate Toxicity
    
- Excessive salivation, miosis, lacrimation, diarrhea, emesis, urination, bronchospasm
 - Bradycardia, heart block, prolonged QTc
 - Treatment
        
- Pralidoxime
            
- Reverses muscle paralysis (nicotinic effects)
 
 - Atropine
 
 - Pralidoxime
            
 
 - Phencyclidine (PCP) Overdose
    
- NMDA and Ach Antagonism
        
- Particularly in the hippocampus and limbic system
 
 - Dopamine, norepinephrine, and serotonin receptor activation
 - Sigma receptor complex activation causing psychotic and anticholinergic effects
 - Lasts <8 hours
 - PCP withdrawal
        
- Depression
 
 - Ketamine is shorter acting
 - Vertical or horizontal nystagmus, ataxia, violent behavior, hyperthermia, disorientation, delusions, muscle rigidity
 - Treatment
        
- Psychomotor Agitation: Parenteral Benzodiazepines (lorazepam, diazepam) ≥ Haloperidol unless seizure disorder is present
            
- B52 – Haloperidol, diphenhydramine, and benzodiazepine
 
 
 - Psychomotor Agitation: Parenteral Benzodiazepines (lorazepam, diazepam) ≥ Haloperidol unless seizure disorder is present
            
 
 - NMDA and Ach Antagonism
        
 - Phenytoin Toxicity
    
- Vertical Nystagmus
        
- Cerebellar-vestibular system affected
 - Sedation, hypotension, arrhythmias, GI disturbances
 - Gingival hyperplasia and hirsutism if long-term use
 
 - 2nd line anticonvulsant (after lorazepam) in treating status epilepticus
 - Decreases repetitive firing of neuronal action potentials by slowing the rate of recovery of voltage gated sodium channels from inactivation
 - SE: SJS
 
 - Vertical Nystagmus
        
 - Salicylate Poisoning
    
- Treatment
        
- Gastric Lavage, Activated charcoal, alkalinization of the urine, diuresis, dialysis
 
 
 - Treatment
        
 - Serotonin Discontinuation Syndrome
    
- RF: SSRIs with short half-life and no active metabolites
        
- MC with short half-life SSRIs (paroxetine ≥ venlafaxine)
 
 - Onset within 3 days of discontinuation, resolution within 1-2 weeks
        
- Fatigue, insomnia, myalgias from abrupt discontinuation in 20%
 - Headaches, anxiety, agitation
 - “Weird” sensations along arms and legs, “electric-shock-like” sensations in head/neck, “rushing” sensations in the head
 - Vertigo, tremor, ataxia
 
 - Treatment
        
- Restart drug and taper gradually over several weeks (6-8 weeks)
 - If persistent, switch to Fluoxetine
 
 
 - RF: SSRIs with short half-life and no active metabolites
        
 - Serotonin Syndrome (SS)
    
- General
        
- Over stimulation of 5-HT receptors in the central grey nuclei and the medulla
            
- MC with stopping sertraline and fluvoxamine
 - Fluoxetine has a long half-life, must be quit 5 weeks prior to MAOI, but doesn’t need to be tapered
                
- Tramadol (Ultram)
 - Serotonergic analgesic + SSRIs
 
 
 
 - Over stimulation of 5-HT receptors in the central grey nuclei and the medulla
            
 - Symptoms
        
- Activity (hyperactivity, hyperreflexia, hypertonia, tremor, seizure)
            
- Myoclonus, Lower extremity rigidity, tremor
 
 - Autonomic (hyperthermia, diaphoresis, diarrhea, mydriasis)
            
- Flushing, Tachycardia, hypertension
 
 - Agitation (Need AMS)
            
- Anxiety, confusion, hypomania, coma
 
 - Headaches, N/V/D, dizziness and fatigue when suddenly stopping
 
 - Activity (hyperactivity, hyperreflexia, hypertonia, tremor, seizure)
            
 - Exam
        
- Hyperreflexia and myoclonus
 - Diaphoresis, hypertension, tachycardia
 - Fever/Hyperthermia, cardiovascular collapse
 
 - Labs
        
- No CPK or liver enzyme changes
 
 - Treatment
        
- Discontinue serotonergic meds, supportive, benzodiazepines, cyproheptadine
 - Cyclobenzaprine
 - Cyproheptadine (H1 receptor antagonist)
            
- Weakly cholinergic hypotension
 
 
 
 - General
        
 - Steroids
    
- Glucocorticoids/Prednisone (Asthma/Lupus)
 - Delusions/hallucinations. Alert and cognitively intact
 - Anxiety, depression, psychosis, mania rarely
 - Usually occur during the first week but may occur at any time
 
 - Tardive Dyskinesia
    
- 98% get worse with acute cessation of antipsychotic
        
- D2 receptor upregulation and super sensitivity
 - Chronic blockade of dopamine receptors causes this
 
 - Treatment
        
- Switch from risperidone to clozapine (atypical antipsychotic)
 - VMAT2 Inhibitors
            
- Blocks presynaptic dopamine release
                
- May cause depletion of dopamine in synaptic cleft causing depression
 
 - Deutetrabenazine (Austedo)
                
- TD and Huntington’s
 
 - Valbenazine (Ingrezza)
 - Reserpine
 
 - Blocks presynaptic dopamine release
                
 
 
 - 98% get worse with acute cessation of antipsychotic
        
 - TCA (Tricarboxylic Acid) Overdose
    
- Features
        
- Antihistamine Effects
            
- Drowsiness, delirium, coma, seizures, respiratory depression
 
 - Anticholinergic Effects
            
- Dry mouth, blurred vision, mydriasis, urinary retention
 - Flushing, hyperthermia
 
 - Hypotension, sinus tachycardia, prolonged PR/QRS/QT, Arrythmias
            
- QRS ≥ 100ms is MC EKG abnormality
 
 - 1500mg for ≥4 hours = death
 
 - Antihistamine Effects
            
 - Treatment
        
- O2 and intubation, EKG monitoring
 - IV fluids
 - Activated charcoal if within 2 hours of ingestion (unless ileus present)
 - Seizures: Benzodiazepines
 - QRS ≥100: IV Sodium Bicarbonate
            
- Therapy for QRS widening or ventricular arrythmia
 - QRS ≥ 100msec is associated with increased risk of arrhythmias and/or seizures
 - Cardioprotective and helps metabolic acidosis
 
 
 
 - Features
        
 - Theophylline Toxicity
    
- Toxic form reduced clearance or decreased metabolism in the liver
 - CNS Stimulation (headache, insomnia, seizures), GI (Nausea, vomiting), and cardiac toxicity (arrhythmia)
 - Measure theophylline levels
 
 - tPA
    
- Treatment
        
- Aminocaproic Acid
 
 
 - Treatment
        
 - Warfarin
    
- Treatment
        
- Vitamin K, FFP
 
 
 - Treatment